Does Mounjaro Affect the Mirena Coil?

Mounjaro slows gastric emptying, which can reduce how well oral medicines are absorbed — but this does not apply to the Mirena coil, which delivers hormones locally rather than by mouth.
The MHRA and NHS England advise that women on oral contraceptives add a non-oral method (such as condoms) for the first four weeks of tirzepatide and for four weeks after each dose increase, this guidance does not extend to the Mirena or other non-oral methods.
Changes to your cycle, spotting or periods are common with the Mirena regardless of tirzepatide; weight loss itself can also alter cycle patterns, so unpicking cause and effect takes a clinical eye.
Always tell your prescriber you have a Mirena in place; and if anything unexpected happens with your cycle or coil after starting treatment, raise it with your GP or prescribing clinician promptly.

Mounjaro (tirzepatide) does not appear to affect the Mirena coil. Because the Mirena works locally inside the uterus rather than being absorbed through the gut, it is not subject to the absorption interaction that tirzepatide raises for oral contraceptives. That said, there are still things worth knowing before you start treatment — and your prescriber should always have the full picture of every medicine you use. Mounjaro is a prescription-only medicine; a clinician assesses suitability before any prescription is issued.

Starting from £29.99/mo

Free 2-minute consultation · Reviewed same day

Start journey
The nume Promise

Order by 12pm.

At your door the next working day.
Free, tracked, plain packaging.

Guaranteed on approved orders

Where are you starting from?

BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.

Check your BMI.

Ten seconds. Private — nothing is stored or shared.

80 kg
170 cm

Your result updates live in the card alongside.

Your result

Your BMI is

which is in the healthy weight range

Start journey

BMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.

Treatment options

Weight loss treatments

The problem

Most weight loss services treat you like a transaction, a checkout, a courier, and you're on your own.

Algorithm approvalsNo real clinicianGeneric dosingHidden feesSlow deliverySilence after checkout

The nume way

We built the opposite: one clinician who knows you, guaranteed care at every step.

24 hrs

clinician review. Free next working day delivery.

How it works

From consultation to your door, properly.

Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.

Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.

Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.

How the coil and tirzepatide interact, and what NHS guidance actually says

Step 1: understand why tirzepatide raises a contraception question at all

Tirzepatide slows the rate at which the stomach empties. That matters for medicines taken by mouth because slower transit means variable absorption, the drug may peak at a different time, or the effective dose reaching the bloodstream may be lower than expected. This is the mechanism behind NHS guidance that women using oral contraceptive pills should use an additional barrier method for the first four weeks of Mounjaro and for four weeks after every dose increase, as noted on NHS England's weight-management injections guidance.

The Mirena coil (formally the levonorgestrel intrauterine system) works differently. It sits inside the uterus and releases a small, continuous amount of levonorgestrel directly into the uterine lining. Almost none of it enters the general circulation, and none of it travels through the gut. Gastric emptying is simply not part of how it works. That is the core reason the oral-pill interaction warning does not carry over to the Mirena.

If you are curious about how tirzepatide more broadly interacts with hormonal contraception, our page on Mounjaro and the Mirena coil covers the topic in more depth.

Step 2: know what might change in your cycle anyway

The Mirena already changes periods for most people, lighter, irregular, or absent bleeding is normal and expected. Tirzepatide adds its own layer. Significant weight loss can shift hormonal patterns: oestrogen stored in fat tissue falls as that tissue reduces, and for some women this temporarily affects their cycle. If you notice new or unusual bleeding after starting Mounjaro, it is genuinely difficult to attribute that to the coil, to the treatment, or to the weight-loss process itself without a clinical assessment.

There is also a separate question worth flagging: if you have been using the Mirena partly for contraception and you lose a meaningful amount of weight, your fertility may return sooner than expected, or differ from what you assumed before treatment. The MHRA advises using effective contraception while taking tirzepatide and through a wash-out period before trying to conceive. For most Mirena users this is already covered, but it is worth confirming with your GP that your contraceptive cover is still appropriate for your circumstances, and our dedicated page on Mounjaro and the coil goes into further detail on exactly that point.

Changes to periods more broadly are something a lot of people on tirzepatide notice. Our page on how Mounjaro can affect your period looks at what the evidence shows.

Step 3: what to tell your prescriber (and when to act quickly)

Before starting Mounjaro, list every medicine, contraceptive and medical device you use. The Mirena counts. It is not because there is a known interaction to manage, it is because a prescriber building your full clinical picture needs the complete list. Our prescribers at nume review every consultation personally, and that review includes your contraception.

If, after starting treatment, you notice any of the following, speak to a clinician promptly: unusual pain in your lower abdomen, unexpected heavy bleeding, signs that the coil may have shifted (your GP can check the threads), or any other change that feels new and unexplained. None of these are common occurrences linked to tirzepatide, but they are always worth investigating quickly regardless of what medicine you are on.

The NHS tirzepatide information page is a reliable reference for what to watch for during treatment generally. For questions specific to how tirzepatide sits alongside other medicines and devices, your prescribing clinician is the right person to ask, not a forum and not a guess.

If you are also on HRT, there is a related consideration: NHS England advises discussing transdermal HRT (patches or gels rather than tablets) with your doctor while on tirzepatide, for the same gut-absorption reason that applies to oral tablets. Our page on Mounjaro and HRT covers that specifically.

For anyone weighing up the broader question of contraception and this treatment, the effect of Mounjaro on the coil is a question our prescribers hear regularly, it reflects how seriously people take getting this right before they begin.

A brief practical note on timing: if you are considering starting treatment and want it reviewed before the school-run rush, nume submits consultations for same-day clinical review on working days, a real prescriber reads your answers, not software. Our Mounjaro pricing page sets out what a private prescription includes, if cost is part of your thinking.

Treatment is one part of the picture. For a broader overview of the weight-management options a prescriber might discuss with you, our weight-loss overview explains how the different approaches fit together.

Looking to start your weight loss journey?
Take a quick eligibility quiz to explore your options and see how we can support you.
Start free consultation

The people

Meet the team.

Mahommed Zunaid Ayub Patel

Superintendent Pharmacist (GPhC No. 2217101)

Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.

Mostafa Damghani

Clinical Lead (GPhC No. 2231744)

Sets our clinical standards and checks everything we publish against current MHRA guidance.

Shelan Salih

Independent Prescriber (GPhC No. 2084501)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Rehenaaz Uddin

Independent Prescriber (GPhC No. 2083426)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Frequently asked questions